Cara Therapeutics Study Site

Bridgeport, Connecticut 06606

0 studies enrolling now · 2 studies all time

What they study most

Hemodialysis, Uremic Pruritus

Studies at this site

• CR845-100303: Study to Assess the Potential of Physical Withdrawal From Intravenous CR845 (Difelikefalin) in Hemodialysis Patients — Completed
• A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1) — Completed